From 14 October 2026, a Dubai professional may use only the title on their DHA licence on every channel, from signage and stamps to their personal Instagram. Ten popular titles are now named as not approved.
DHA circular CIR-2026-00000184 (DHA/OUT/2026/0001199), dated 14 October 2026 and in force on issuance, requires every Dubai healthcare professional and facility to use only the title in the DHA-issued licence, on signage, stamps, badges, websites, advertising, telehealth apps and personal social media accounts. It names ten titles as not approved, among them Laser Specialist, Aesthetic Specialist, Functional Medicine Specialist, Stem Cell Specialist and Cosmetic Dentistry Specialist, bars a General Practitioner from calling themselves a Specialist Physician, stops owners and administrators using medical titles, and requires non-compliant titles to be corrected or removed immediately. For a buyer of an aesthetic, dental, longevity or wellness clinic, the question is how much revenue sits with practitioners marketed beyond their licence.
What a board member needs before the next meeting on this.
- It is in force now, with no transition. The circular is dated 14 October 2026 and takes effect on the date of issuance. Clause 12 requires any misleading title, or one inconsistent with the licence, to be corrected or removed immediately.
- Ten titles are named, and the list is open. Laser Specialist, Aesthetic Specialist, Functional Medicine Specialist, Stem Cell Specialist, Injection Specialist, Naturopathy Physician Specialist, Smile Specialist, Cosmetic Dentistry Specialist, Physiotherapy Consultant and Pharmacy Consultant, plus any other title the DHA has not approved. A General Practitioner may not use Specialist Physician.
- Personal accounts are inside scope. Clause 13 applies the circular to digital platforms, telehealth applications, websites and the personal as well as official social media accounts of professionals and facilities in Dubai. Clause 5 bars owners, administrators and unlicensed persons from using any medical title to promote themselves or the facility.
- The facility owns the check. Clause 10 makes the facility responsible for verifying titles before publication and for a standardised internal display mechanism. Clause 11 obliges it to produce, on request, the documents that substantiate every title and academic designation used.
On 14 October 2026 the Dubai Health Authority issued an external circular, reference DHA/OUT/2026/0001199 and published on Sheryan as CIR-2026-00000184, requiring every DHA-licensed healthcare professional and facility to use only the professional title written in the DHA-issued licence (DHA circular CIR-2026-00000184; DHA circulars index). It took effect on the date of issuance.
There is no transition period and no allowance for content already published: clause 12 requires any title inconsistent with the licence to be corrected or removed immediately. For a buyer of a Dubai aesthetic, dental, longevity or wellness clinic, the circular turns a marketing habit into a licence question, in exactly the categories where the habit is most common.
The regulator has named the titles
Clause 3 of the circular lists ten titles as not recognised or not approved because they are not aligned with the Unified Healthcare Professional Qualification Requirements: Laser Specialist, Aesthetic Specialist, Functional Medicine Specialist, Stem Cell Specialist, Injection Specialist, Naturopathy Physician Specialist, Smile Specialist, Cosmetic Dentistry Specialist, Physiotherapy Consultant and Pharmacy Consultant (CIR-2026-00000184). The list is expressly non-exhaustive and closes on any other title the DHA has not approved.
The same clause bars a professional licensed as a General Practitioner from calling themselves a Specialist Physician. Clause 9 extends the rule to promotional descriptors such as Advisor or Expert where they imply a professional title or clinical specialty. Read that list against the Dubai clinics selling injectables, lasers, regenerative treatments, veneers and longevity programmes, and it describes the front page of many of their websites.
The rule reaches surfaces the clinic does not control
Clause 2 requires titles on internal and external signage, stamps, identification badges, printed materials, websites, social media and advertising to match the licence details registered with the Authority. Clause 13 applies the circular to all digital platforms, telehealth applications, websites, and the personal as well as official social media accounts of professionals and facilities in Dubai.
That last phrase matters most. A clinic can correct its own website in an afternoon. It controls the personal profile of a star injector only through an employment contract, and that profile frequently carries one of the titles the circular now names.
Clause 5 bars administrators, owners and anyone not licensed to practise from using any medical or professional title to promote themselves or the facility, which reaches the founder-led brand where the owner is the face of the clinic without holding a clinical licence.
Get the instruments that touch your licence, assessed, as they are issued. See Regulatory Watch
The facility carries the check
Clause 10 makes health facilities responsible for reviewing the titles their professionals use and verifying them before publication in any promotional or informational material, and requires a standardised internal mechanism for displaying titles. Clause 11 obliges facilities to provide, on request, the documents substantiating every professional title and academic designation used.
Clause 8 permits Professor, Associate Professor and Assistant Professor only on a verifiable appointment from a recognised UAE institution, stated alongside the licensed title; clause 7 limits Doctor to physicians and dentists with a recognised qualification and to holders of a recognised doctorate in their field. The circular sets no penalty of its own. It closes by telling recipients to comply fully and avoid legal liability, leaving the consequence to the wider DHA framework rather than to a figure in the circular.
Where this becomes a price
The visible cost is the rebrand: signage, stamps, badges, printed stock, website copy, paid-ad creative and every practitioner profile. That cost is real and finite. The larger question is commercial. Some clinics are built around a practitioner marketed as an aesthetic, laser or functional-medicine specialist whose DHA licence records a different title.
If patients book that person for a specialism the licence does not record, renaming a bio does not close the issue. Clause 1 bars any title that exceeds the licensed scope of practice, and clause 4 requires every professional to practise within their licensure specialty and granted clinical privileges, so the diligence question moves from marketing to what the practitioner is privileged to do.
On our read, a clinic whose top revenue producers are marketed beyond their licence carries two exposures: a regulatory one now, and a demand one if the title was the reason patients came. The rule is not wholly new.
Clause 6.1 of the social media advertising standard DHA re-circulated in August as CIR-2026-00000144 (ST-21, effective 3 October 2022) already barred off-licence titles in social media advertising, Aesthetic Specialist among them (our brief on that standard). This circular extends the rule to every channel and names ten titles; on our reading, a target using one on Instagram has been out of line since 2022.
What to do before signing
Pull the DHA licence record for every practitioner the target markets by name, and set the licensed title beside the title used on the website, signage, booking platforms, paid ads and each practitioner's personal social accounts. Mark every use of the ten named titles, every General Practitioner presented as a Specialist Physician, every unsupported Doctor or Professor, and every owner or administrator shown with a clinical title.
Then map revenue by practitioner for the last twelve months and isolate the share that sits with professionals whose marketed title differs from their licence. That share, not the rebrand invoice, decides whether the finding is a warranty and a pre-completion covenant in the sale and purchase agreement or a reason to revisit price. That is where our buy-side M&A practice begins.
Four questions before buying a Dubai clinic
- For every practitioner the clinic markets by name, does the title on the website, signage, booking platforms, paid ads and personal social accounts match the title on the DHA licence?
- What share of the last twelve months' revenue was generated by practitioners marketed under one of the ten named titles, or under any title their licence does not record?
- Is any owner, founder or administrator presented to patients with a medical or professional title they are not licensed to use?
- Can the clinic produce today the clause 10 review record and the clause 11 documents substantiating every title and academic designation it publishes?
This brief covers one instrument. The UAE healthcare regulatory tracker carries the full set — DoH, DHA, EDE and the other emirates — with what each one changes and when it takes effect.
Subscribe
The UAE healthcare regulatory briefing
What changed, what it reprices, and the instrument to read. Every second Tuesday. No pitches.
One email a fortnight. Unsubscribe from any of them.